Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation
Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Poly...
Saved in:
Published in | Drug metabolism and pharmacokinetics Vol. 30; no. 1; pp. 119 - 122 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension. |
---|---|
AbstractList | Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension.Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension. Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension. Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension. |
Author | Tsukada, Chiharu Hosono, Hiroki Saito, Takahiro Ito, Miyabi Honda, Masashi Takahashi, Masamitsu Hiratsuka, Masahiro Katono, Yuki Suzuki, Naoto Hirasawa, Noriyasu Saigusa, Daisuke Tomioka, Yoshihisa |
Author_xml | – sequence: 1 givenname: Takahiro surname: Saito fullname: Saito, Takahiro organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 2 givenname: Masashi surname: Honda fullname: Honda, Masashi organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 3 givenname: Masamitsu surname: Takahashi fullname: Takahashi, Masamitsu organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 4 givenname: Chiharu surname: Tsukada fullname: Tsukada, Chiharu organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 5 givenname: Miyabi surname: Ito fullname: Ito, Miyabi organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 6 givenname: Yuki surname: Katono fullname: Katono, Yuki organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 7 givenname: Hiroki surname: Hosono fullname: Hosono, Hiroki organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 8 givenname: Daisuke surname: Saigusa fullname: Saigusa, Daisuke organization: Department of Integrative Genomics, Tohoku Medical Megabank, Tohoku University, Sendai, Japan – sequence: 9 givenname: Naoto surname: Suzuki fullname: Suzuki, Naoto organization: Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 10 givenname: Yoshihisa surname: Tomioka fullname: Tomioka, Yoshihisa organization: Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 11 givenname: Noriyasu surname: Hirasawa fullname: Hirasawa, Noriyasu organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan – sequence: 12 givenname: Masahiro surname: Hiratsuka fullname: Hiratsuka, Masahiro email: mhira@m.tohoku.ac.jp organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25760539$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kb1uFDEUhS0URH7gBSiQS5oZ7PGMdyzRRKsEkCJBAQWVdce-w3rxjhfbu2Ip6fJ0eSU82UBBkepaV-c7Vz7nnJxMYUJCXnJWc8blm3VtN9vvdcN4WzNVM8afkDPe96xiqmEn5S3aRdUKuTgl5ymtGROia5tn5LTpFpJ1Qp2R39e7yWQXJvDUrCCCyRjdL5hXNIyUM7r8-qm95JyC9-idoXuIDqacaA4U9-B3kJHmFVIcRzR5pr7hFPJhi7SYzJ4rZ8NUUDDO0rvbanWwMfw8-Pszz8nTEXzCFw_zgny5vvq8fF_dfHz3YXl5UxnRs1x1rOHdKAZopJWco7KsF73teiEHGDiHBYdGmQEAhVGmDK5kr8qXhek6q8QFeX303cbwY4cp641LBr2HCcMuaS6lkJ1s1Sx99SDdDRu0ehvdBuJB_82tCJqjwMSQUsTxn4QzPZej13ouR8_laKZ0KadA_X-Qcfk-ghzB-cfRt0cUS0B7h1En43AyaF0smWsb3GP4H86Yq6k |
CitedBy_id | crossref_primary_10_1016_j_dmpk_2016_09_003 crossref_primary_10_1016_j_cbi_2023_110644 crossref_primary_10_3390_ijms20184500 crossref_primary_10_62347_VLGD3371 crossref_primary_10_1016_j_heliyon_2023_e21308 crossref_primary_10_1124_dmd_123_001389 crossref_primary_10_1016_j_forsciint_2020_110293 crossref_primary_10_1124_jpet_118_249557 |
Cites_doi | 10.1038/314620a0 10.1161/HYPERTENSIONAHA.108.114082 10.1016/j.gene.2012.10.007 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D 10.1016/S0022-3565(24)37530-5 10.1681/ASN.2008010063 10.1111/j.1601-5223.2012.02247.x 10.1016/j.gene.2011.07.015 10.1161/01.HYP.13.5_Suppl.I13 10.1038/10297 10.1161/01.RES.72.1.126 10.1161/01.HYP.0000182658.04299.15 10.1097/HJH.0b013e32834aa786 10.1161/01.CIR.0000151309.82473.59 10.1172/JCI119279 10.1177/1076029611436197 10.1097/HJH.0b013e3282f2f10c 10.1007/s11886-006-0098-7 |
ContentType | Journal Article |
Copyright | 2014 The Japanese Society for the Study of Xenobiotics Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2014 The Japanese Society for the Study of Xenobiotics – notice: Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.dmpk.2014.09.001 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1880-0920 |
EndPage | 122 |
ExternalDocumentID | 25760539 10_1016_j_dmpk_2014_09_001 S1347436714000020 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --M 0R~ 29G 2WC 4.4 457 53G 5GY 7-5 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXUO ABJNI ABMAC ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BAWUL BKOJK BKOMP BLXMC CS3 DIK DU5 E3Z EBS EFJIC EFLBG EJD F5P FDB FEDTE FIRID FYGXN GBLVA GX1 HH5 HVGLF HZ~ JMI JSF JSH KOM KQ8 M41 MOJWN M~E O9- OAUVE RJT RNS ROL RZJ SPCBC SSP SSZ T5K TKC TR2 ~G- AAQFI AATTM AAXKI AAYWO AAYXX ACVFH ADCNI AEIPS AEUPX AFJKZ AFPUW AGCQF AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION OVT SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 |
ID | FETCH-LOGICAL-c380t-50215f3ba26d611e9d0838d5836bab11a71a29cbaae3c9caae196893353c55d93 |
IEDL.DBID | AIKHN |
ISSN | 1347-4367 1880-0920 |
IngestDate | Fri Jul 11 07:24:27 EDT 2025 Mon Jul 21 06:01:22 EDT 2025 Tue Jul 01 05:05:44 EDT 2025 Thu Apr 24 22:58:36 EDT 2025 Fri Feb 23 02:32:23 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Hypertension 20-HETE Arachidonic acid Cytochrome P450 Genetic polymorphisms CYP4A11 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c380t-50215f3ba26d611e9d0838d5836bab11a71a29cbaae3c9caae196893353c55d93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25760539 |
PQID | 1663656499 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1663656499 pubmed_primary_25760539 crossref_primary_10_1016_j_dmpk_2014_09_001 crossref_citationtrail_10_1016_j_dmpk_2014_09_001 elsevier_sciencedirect_doi_10_1016_j_dmpk_2014_09_001 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-02-01 |
PublicationDateYYYYMMDD | 2015-02-01 |
PublicationDate_xml | – month: 02 year: 2015 text: 2015-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Drug metabolism and pharmacokinetics |
PublicationTitleAlternate | Drug Metab Pharmacokinet |
PublicationYear | 2015 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Barri (bib2) 2006; 8 Ma, Gebremedhin, Schwartzman, Falck, Clark, Masters (bib5) 1993; 72 Halushka, Fan, Bentley, Hsie, Shen, Weder (bib3) 1999; 22 Sugimoto, Akasaka, Katsuya, Node, Fujisawa, Shimaoka (bib8) 2008; 52 Williams, Hopkins, Jeunemaitre, Brown (bib15) 2011; 29 Nowicki, Chen, Aizman, Cheng, Li, Nowicki (bib7) 1997; 99 Fu, Yang, Ma, Huang, Xie, Zheng (bib10) 2013; 512 Fu, Ma, Xie, Huang, Yang, Nakayama (bib9) 2013; 19 Powell, Wolf, Jin, Lasker (bib16) 1998; 285 Chang, Loew (bib17) 1999; 34 Stokes, Kannel, Wolf, D'Agostino, Cupples (bib1) 1989; 13 Fu, Nakayama, Sato, Izumi, Kasamaki, Shindo (bib14) 2008; 26 Gainer, Lipkowitz, Yu, Waterman, Dawson, Capdevila (bib20) 2008; 19 Lino Cardenas, Renault, Farce, Cauffiez, Allorge, Lo-Guidice (bib18) 2011; 487 (bib19) 1993 Schwartzman, Ferreri, Carroll, Songu-Mize, McGiff (bib6) 1985; 314 Fu, Nakayama, Sato, Izumi, Kasamaki, Shindo (bib11) 2012; 149 Mayer, Lieb, Gotz, Konig, Aherrahrou, Thiemig (bib13) 2005; 46 Zou, Fleming, Falck, Jacobs, Gebremedhin, Harder (bib4) 1996; 270 Gainer, Bellamine, Dawson, Womble, Grant, Wang (bib12) 2005; 111 Ma (10.1016/j.dmpk.2014.09.001_bib5) 1993; 72 Zou (10.1016/j.dmpk.2014.09.001_bib4) 1996; 270 (10.1016/j.dmpk.2014.09.001_bib19) 1993 Gainer (10.1016/j.dmpk.2014.09.001_bib12) 2005; 111 Mayer (10.1016/j.dmpk.2014.09.001_bib13) 2005; 46 Sugimoto (10.1016/j.dmpk.2014.09.001_bib8) 2008; 52 Lino Cardenas (10.1016/j.dmpk.2014.09.001_bib18) 2011; 487 Fu (10.1016/j.dmpk.2014.09.001_bib11) 2012; 149 Williams (10.1016/j.dmpk.2014.09.001_bib15) 2011; 29 Powell (10.1016/j.dmpk.2014.09.001_bib16) 1998; 285 Schwartzman (10.1016/j.dmpk.2014.09.001_bib6) 1985; 314 Fu (10.1016/j.dmpk.2014.09.001_bib14) 2008; 26 Fu (10.1016/j.dmpk.2014.09.001_bib9) 2013; 19 Fu (10.1016/j.dmpk.2014.09.001_bib10) 2013; 512 Barri (10.1016/j.dmpk.2014.09.001_bib2) 2006; 8 Gainer (10.1016/j.dmpk.2014.09.001_bib20) 2008; 19 Stokes (10.1016/j.dmpk.2014.09.001_bib1) 1989; 13 Nowicki (10.1016/j.dmpk.2014.09.001_bib7) 1997; 99 Chang (10.1016/j.dmpk.2014.09.001_bib17) 1999; 34 Halushka (10.1016/j.dmpk.2014.09.001_bib3) 1999; 22 |
References_xml | – volume: 22 start-page: 239 year: 1999 end-page: 247 ident: bib3 article-title: Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis publication-title: Nat Genet – volume: 13 start-page: I13 year: 1989 end-page: I18 ident: bib1 article-title: Blood pressure as a risk factor for cardiovascular disease. The Framingham Study–30 years of follow-up publication-title: Hypertension – volume: 270 start-page: R228 year: 1996 end-page: R237 ident: bib4 article-title: 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles publication-title: Am J Physiol – volume: 512 start-page: 510 year: 2013 end-page: 516 ident: bib10 article-title: Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China publication-title: Gene – volume: 314 start-page: 620 year: 1985 end-page: 622 ident: bib6 article-title: Renal cytochrome P450-related arachidonate metabolite inhibits (Na publication-title: Nature – year: 1993 ident: bib19 publication-title: Cytochrome P-450 – volume: 29 start-page: 1913 year: 2011 end-page: 1918 ident: bib15 article-title: CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow publication-title: J Hypertens – volume: 487 start-page: 10 year: 2011 end-page: 20 ident: bib18 article-title: Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population publication-title: Gene – volume: 99 start-page: 1224 year: 1997 end-page: 1230 ident: bib7 article-title: 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na publication-title: J Clin Invest – volume: 46 start-page: 766 year: 2005 end-page: 771 ident: bib13 article-title: Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy publication-title: Hypertension – volume: 34 start-page: 403 year: 1999 end-page: 415 ident: bib17 article-title: Homology modeling and substrate binding study of human CYP4A11 enzyme publication-title: Proteins – volume: 72 start-page: 126 year: 1993 end-page: 136 ident: bib5 article-title: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries publication-title: Circ Res – volume: 285 start-page: 1327 year: 1998 end-page: 1336 ident: bib16 article-title: Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11 publication-title: J Pharmacol Exp Ther – volume: 52 start-page: 1142 year: 2008 end-page: 1148 ident: bib8 article-title: A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population publication-title: Hypertension – volume: 8 start-page: 411 year: 2006 end-page: 417 ident: bib2 article-title: Hypertension and kidney disease: a deadly connection publication-title: Curr Cardiol Rep – volume: 149 start-page: 91 year: 2012 end-page: 98 ident: bib11 article-title: Haplotype-based case-control study of CYP4A11 gene and myocardial infarction publication-title: Hereditas – volume: 26 start-page: 453 year: 2008 end-page: 461 ident: bib14 article-title: A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men publication-title: J Hypertens – volume: 111 start-page: 63 year: 2005 end-page: 69 ident: bib12 article-title: Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension publication-title: Circulation – volume: 19 start-page: 1606 year: 2008 end-page: 1612 ident: bib20 article-title: Association of a CYP4A11 variant and blood pressure in black men publication-title: J Am Soc Nephrol – volume: 19 start-page: 60 year: 2013 end-page: 65 ident: bib9 article-title: A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease publication-title: Clin Appl Thromb Hemost – volume: 314 start-page: 620 year: 1985 ident: 10.1016/j.dmpk.2014.09.001_bib6 article-title: Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase publication-title: Nature doi: 10.1038/314620a0 – volume: 52 start-page: 1142 year: 2008 ident: 10.1016/j.dmpk.2014.09.001_bib8 article-title: A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.108.114082 – volume: 512 start-page: 510 year: 2013 ident: 10.1016/j.dmpk.2014.09.001_bib10 article-title: Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China publication-title: Gene doi: 10.1016/j.gene.2012.10.007 – volume: 270 start-page: R228 year: 1996 ident: 10.1016/j.dmpk.2014.09.001_bib4 article-title: 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles publication-title: Am J Physiol – volume: 34 start-page: 403 year: 1999 ident: 10.1016/j.dmpk.2014.09.001_bib17 article-title: Homology modeling and substrate binding study of human CYP4A11 enzyme publication-title: Proteins doi: 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D – volume: 285 start-page: 1327 year: 1998 ident: 10.1016/j.dmpk.2014.09.001_bib16 article-title: Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)37530-5 – volume: 19 start-page: 1606 year: 2008 ident: 10.1016/j.dmpk.2014.09.001_bib20 article-title: Association of a CYP4A11 variant and blood pressure in black men publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2008010063 – volume: 149 start-page: 91 year: 2012 ident: 10.1016/j.dmpk.2014.09.001_bib11 article-title: Haplotype-based case-control study of CYP4A11 gene and myocardial infarction publication-title: Hereditas doi: 10.1111/j.1601-5223.2012.02247.x – volume: 487 start-page: 10 year: 2011 ident: 10.1016/j.dmpk.2014.09.001_bib18 article-title: Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population publication-title: Gene doi: 10.1016/j.gene.2011.07.015 – volume: 13 start-page: I13 year: 1989 ident: 10.1016/j.dmpk.2014.09.001_bib1 article-title: Blood pressure as a risk factor for cardiovascular disease. The Framingham Study–30 years of follow-up publication-title: Hypertension doi: 10.1161/01.HYP.13.5_Suppl.I13 – volume: 22 start-page: 239 year: 1999 ident: 10.1016/j.dmpk.2014.09.001_bib3 article-title: Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis publication-title: Nat Genet doi: 10.1038/10297 – volume: 72 start-page: 126 year: 1993 ident: 10.1016/j.dmpk.2014.09.001_bib5 article-title: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries publication-title: Circ Res doi: 10.1161/01.RES.72.1.126 – volume: 46 start-page: 766 year: 2005 ident: 10.1016/j.dmpk.2014.09.001_bib13 article-title: Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy publication-title: Hypertension doi: 10.1161/01.HYP.0000182658.04299.15 – volume: 29 start-page: 1913 year: 2011 ident: 10.1016/j.dmpk.2014.09.001_bib15 article-title: CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow publication-title: J Hypertens doi: 10.1097/HJH.0b013e32834aa786 – volume: 111 start-page: 63 year: 2005 ident: 10.1016/j.dmpk.2014.09.001_bib12 article-title: Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension publication-title: Circulation doi: 10.1161/01.CIR.0000151309.82473.59 – year: 1993 ident: 10.1016/j.dmpk.2014.09.001_bib19 – volume: 99 start-page: 1224 year: 1997 ident: 10.1016/j.dmpk.2014.09.001_bib7 article-title: 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase publication-title: J Clin Invest doi: 10.1172/JCI119279 – volume: 19 start-page: 60 year: 2013 ident: 10.1016/j.dmpk.2014.09.001_bib9 article-title: A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease publication-title: Clin Appl Thromb Hemost doi: 10.1177/1076029611436197 – volume: 26 start-page: 453 year: 2008 ident: 10.1016/j.dmpk.2014.09.001_bib14 article-title: A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men publication-title: J Hypertens doi: 10.1097/HJH.0b013e3282f2f10c – volume: 8 start-page: 411 year: 2006 ident: 10.1016/j.dmpk.2014.09.001_bib2 article-title: Hypertension and kidney disease: a deadly connection publication-title: Curr Cardiol Rep doi: 10.1007/s11886-006-0098-7 |
SSID | ssj0033542 |
Score | 2.0825913 |
Snippet | Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid.... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 119 |
SubjectTerms | 20-HETE Alleles Animals Arachidonic acid Arachidonic Acid - metabolism Cercopithecus aethiops COS Cells CYP4A11 Cytochrome P-450 CYP4A Cytochrome P-450 Enzyme System - genetics Cytochrome P-450 Enzyme System - metabolism Cytochrome P450 Genetic polymorphisms Genotype Humans Hydroxylation Hypertension Mutagenesis, Site-Directed Polymorphism, Single Nucleotide Transfection |
Title | Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation |
URI | https://dx.doi.org/10.1016/j.dmpk.2014.09.001 https://www.ncbi.nlm.nih.gov/pubmed/25760539 https://www.proquest.com/docview/1663656499 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEB216YUL4ptAqRYJ9UKteLNeZ32MIkIAUUWilcJptV9WDSWJaIqUa2_8uv6lzmTXqZCgB06WrV3b2h3PvF2_eQPwZuBVXQqDxhv6dYYRImTWBJmZ3PqBLYjaQInCn4_LyWnxcSZnOzBqc2GIVpl8f_TpG2-drvTSaPaWTdP7QkmQhShJcW7zQ20X9voYXfMO7A0_fJoctw5ZCLmpoUPtM-qQcmcizcv_WH4nhleUO021Yf4Sn_6FPzdxaPwA7icAyYbxHR_CTpg_gsNpVKBeH7GT24SqiyN2yKa32tTrx3A1xjgWt_-Y22o1x1RMtqgZz9no67QYcs6oyMp549gvXE0TWYatFixpgweGsJFFKgj1IqFX2stleBO651njSXGXGdd4dv07O1t7YstE2t0TOB2_OxlNslSGIXNC5atMEiyohTX90pech8ojbFNeKlFaYzk3A276lbPGBOEqhwf8qhEGCSmclL4ST6EzX8zDc2DSqBo9Gs99XZK2mOK58oUXSpVK2arsAm8HX7ukUU6lMs51S0b7pmnCNE2Yziti5HXh7bbPMip03NlatnOq_7AzjSHkzn6vWwPQ-AHSXxUzD4vLC80RsyEoxpVjF55Fy9i-B63m0MtVL_7zqS_hHp7JyBLfh87q52V4hSBoZQ-SkR_A7vsZvwG-wQam |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NjtMwELZWuwe4IP4pv4MEe2GjxkmcOgcO1ULV0t2qEl1pORnHdrRZlraiXVCv3HgeHoRXYqZ2ukKCPSDtKVJiO5ZnPDNOvvmGsRcdK6s81ai8Lqki9BAuKrUTkY5L2ykzgjZQovDhKO8fZe-OxfEW-9nkwhCsMth-b9PX1jrcaYfVbM_ruv2ekiCzNCfGufUPtYCsHLrVNzy3LV4P3qCQXyZJ7-1kvx-F0gKRSWW8jAS5uiotdZLbnHNXWAxFpBUyzUtdcq47XCeFKbV2qSkMXlBTqTK9SI0QlhiY0O7vEBsWbqud7mDYHzUOAButa_bQ_CKaYMjV8bAy-3n-iRBlnl411KL5iz_8V7y79nu9m-xGCFih69fkFtty09tsd-wZr1d7MLlI4FrswS6ML7iwV3fY9x76Tf-5EcyGG9qnfsKsAh7D_odx1uUcqKjLWW3gK57eCZwDyxkELnIHGKaCh55QLyKWpW_HgIPQmCe1JYZf0Ka28OtHdLKyhM7xML-77OhKZHOPbU9nU_eAgdCyQgvKY1vlxGUmeSxtZlMpcynLIm8x3iy-MoETnUpznKkG_HaqSGCKBKbighCALfZq02fuGUEubS0amao_9Fqhy7q03_NGARRuePqLo6dudr5QHGNEDMLxpNpi971mbOZBp0e0qsXD_3zrM3atPzk8UAeD0fARu45PhEeoP2bbyy_n7gkGYMvyaVB4YB-veo_9Bt0sQlw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+characterization+of+10+CYP4A11+allelic+variants+to+evaluate+the+effect+of+genotype+on+arachidonic+acid+%CF%89-hydroxylation&rft.jtitle=Drug+metabolism+and+pharmacokinetics&rft.au=Saito%2C+Takahiro&rft.au=Honda%2C+Masashi&rft.au=Takahashi%2C+Masamitsu&rft.au=Tsukada%2C+Chiharu&rft.date=2015-02-01&rft.eissn=1880-0920&rft.volume=30&rft.issue=1&rft.spage=119&rft_id=info:doi/10.1016%2Fj.dmpk.2014.09.001&rft_id=info%3Apmid%2F25760539&rft.externalDocID=25760539 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-4367&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-4367&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-4367&client=summon |